肝核受体在胆固醇转化为胆固醇癌的病理学中

Inyoung Cheon1, Minwook Kim2, Kang Ho Kim3

  • 1Department of Anesthesiology, Critical Care, and Pain Medicine and Center for Perioperative Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas; Department of Molecular Medicine and Inflammation-Cancer Microenvironment Research Center, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.

PubMed
概括

肝核受体 (NRs) 是胆汁流调节和肝癌发展的关键. 针对这些NR提供了一种有前途的策略,用于预防和治疗胆固醇酶相关胆固醇癌 (CCA).